Alzchem Group AG
Daniel Rackl is a Laboratory Manager at AlzChem Group AG since February 2019, overseeing a team in the development and implementation of new chemical syntheses on a commercial scale while focusing on troubleshooting and process improvement. Prior to this role, Daniel held postdoctoral researcher positions at Bayer AG and Emory University, where responsibilities included the integration of synthetic methods into discovery and process chemistry and technology evaluation in agrochemical development. Daniel Rackl earned a Doctor of Philosophy (PhD) in Organic Chemistry and a Master of Science (M.Sc.) in Chemistry from the University of Regensburg, along with a Bachelor of Science (B.Sc.) from the University of Arkansas and dual Bachelor of Science degrees from the University of Regensburg, supplemented by an ERASMUS semester at University College Dublin.
This person is not in any teams
Alzchem Group AG
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem benefits from the three very different global developments climate change, population growth and longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting social goals in a multitude of different applications. The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are the company's response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,630 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of around EUR 422.3 million and EBITDA of around EUR 62.0 million in 2021.